These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5560177)

  • 1. [Sensitivity test of Antineoplastic agent sensitivity test in the terminal stage of lung cancer].
    Tanaka H; Inoue M
    Saishin Igaku; 1971 May; 26(5):999-1000. PubMed ID: 5560177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy effectiveness in lung cancer].
    Korman DB; Mikaélian SG
    Sov Med; 1980; (1):28-33. PubMed ID: 7367974
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug sensitivity test of cultured human cancer cells--assay for microcolonies inhibition test].
    Kitano M; Nagase T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):590-8. PubMed ID: 7184416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo sensitivity test of anti-cancer drugs against malignant lung tumor xeno-graft].
    Kitano M
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1175-80. PubMed ID: 6088834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of antineoplastic drug therapy in advanced lung cancer].
    Rey JC; Pilheu JA; González Montaner LJ; Botto HG; Silva H; Manzano R
    Torax; 1967 Sep; 16(3):125-34. PubMed ID: 5618231
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
    Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
    Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy for metastatic lung cancer].
    Ota K; Ariyoshi Y; Urata A
    Gan No Rinsho; 1983 May; 29(6):533-7. PubMed ID: 6876421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Order-made therapy for early lung cancer patients].
    Kawamura M; Oyama T; Inoue Y; Saito Y; Abiko T; Hangai N; Kobayashi K
    Kyobu Geka; 2001 Oct; 54(11):962-7. PubMed ID: 11593736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer].
    Goldobenko GV; Kanaev SV
    Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary metastasis from primary lung cancer and its treatment].
    Furuse K; Kawahara M; Arai R; Turuta S; Konnai Y; Yamamoto S; Hashimoto T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):964-71. PubMed ID: 6307187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro sensitivity of epidermoid lung cancer to cytostatics depending upon the degree of tumor differentiation].
    Grants EA; Berzin'sh IuA; Plegere DA; Zitare IIa; Murnietse EV
    Vopr Onkol; 1984; 30(11):48-51. PubMed ID: 6516260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of multimodality therapy in locoregional non-small cell lung cancer.
    Martini N; Kris MG; Ginsberg RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):769-91. PubMed ID: 9309093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of lung cancer: critical review of new agents].
    Spataro V
    Rev Med Suisse; 2005 Feb; 1(8):575-81. PubMed ID: 15794308
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporating bortezomib into the treatment of lung cancer.
    Davies AM; Lara PN; Mack PC; Gandara DR
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4647-51. PubMed ID: 17671158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.
    Jensen PB
    Dan Med Bull; 1994 Nov; 41(5):475-88. PubMed ID: 7859516
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yano S; Zhang H; Hanibuchi M; Miki T; Goto H; Uehara H; Sone S
    Clin Cancer Res; 2003 Nov; 9(14):5380-5. PubMed ID: 14614023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and nonsurgical therapy for lung metastasis: indications and outcomes.
    Demmy TL; Dunn KB
    Surg Oncol Clin N Am; 2007 Jul; 16(3):579-605, ix. PubMed ID: 17606195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological therapy in non-small-cell lung cancer (NSCLC)].
    Souquet PJ
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S53-4S56. PubMed ID: 15687996
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib for small cell lung cancer, aiming for a target in vivo.
    Johnson BE
    Clin Cancer Res; 2004 May; 10(10):3235-6. PubMed ID: 15161675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.